Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma

Journal of Immunotherapy

Volumn 23, Issue 1, 2000, Pages 17-27

  Kawakami, Yutaka ^a,b   Dang, Nita ^a   Wang, Xiang ^a   Tupesis, Janis ^a   Robbins, Paul F ^a   Wang, Rong Fu ^a   Wunderlich, John R ^a   Yannelli, John R ^a,c   Rosenberg, Steven A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

HLA A alleles; Melanoma antigens; Tumor infiltrating lymphocytes

Indexed keywords

HLA ANTIGEN; INTERLEUKIN 2; M PROTEIN; MELANOMA ANTIGEN; MONOPHENOL MONOOXYGENASE;

ADOPTIVE IMMUNOTHERAPY; ALLELE; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MELANOMA; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE;

ALLELES; ANTIGENS, NEOPLASM; HLA-A ANTIGENS; HLA-A1 ANTIGEN; HLA-A2 ANTIGEN; HLA-A3 ANTIGEN; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MELANOMA; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; T-LYMPHOCYTE SUBSETS; TUMOR CELLS, CULTURED;

EID: 0033949981     PISSN: 10538550     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002371-200001000-00004     Document Type: Article

References (45)

1. Darrow TL, Quinn-Allen MA, Crowley NJ, Seigler HF. Modulation of in vitro autologous melanoma-specific cytotoxic T-cell responses by phorbol dibutyrate and ionomycin. Cell Immunol 1990; 125:508-17.
2. Hom SS, Topalian SL, Simoni ST, Mancini MJ, Rosenberg SA. Common expression of melanoma tumor-associated antigens recognized by human tumor-infiltrating lymphocytes: analysis by human lymphocyte antigen restriction. J Immunother 1991;10:153-64.
3. Kawakami Y, Zakut R, Topalian SL, Stotter H, Rosenberg SA. Shared human melanoma antigens. Recognition by tumor infiltrating lymphocytes in HLA-A2.1 transfected melanomas. J Immunol 1992;148:638-43.
4. O'Neil BH, Kawakami Y, Restifo NP, Bennink JR, Yewdell JW, Rosenberg SA. Detection of shared MHC-restricted human melanoma antigens after vaccinia virus-mediated transduction of genes coding for HLA. J Immunol 1993;151:1410-8.
5. Horn SS, Schwartzentruber DJ, Rosenberg SA, Topalian SL. Specific release of cytokines by lymphocytes infiltrating human melanomas in response to shared melanoma antigens. J Immunother 1993;13:18-30.
6. Storkus WJ, Zeh HJ, Maeurer MJ, Salter RD, Lotze MT. Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes. J Immunol 1993;151: 3719-27.
7. Slingluff CL Jr, Cox AL, Henderson RA, Hunt DF, Engelhard VH. Recognition of human melanoma cells by HLA-A2.1-restricted cytotoxic T lymphocytes is mediated by at least six shared peptide epitopes. J Immunol 1993;150:2955-63.
8. Brichard V, Van Pel A, Wolfel T, et al. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1993;178:489-95.
9. Robbins PF, El-Gamil M, Kawakami Y, Stevens E, Yannelh J, Rosenberg SA. Recognition of tyrosinase by tumor infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res 1994;54:3124-6.
10. Kawakami Y, Eliyahu S, Delgaldo CH, et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 1994;91:3515-9.
11. Coulie PG, Brichard V, Van Pel A, et al. New gene coding tor a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994;180:35-42.
12. Bakker ABH, Schreurs MWJ, de Boer AJ, et al. Melanocyte lineage-specific antigen gp100 is recognized by melanocyte-derived tumor-infiltrating lymphocytes. J Exp Med 1994;179:1005-9.
13. Kawakami Y, Eliyahu S, Delgado CH, et al. Identification of a human melanoma antigen recognized by tumor infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 1994;91:6458-62.
14. Cox AL, Skipper J, Cehn Y, et al. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 1994;264:716-9.
15. Robbins PF, El-Gamil M, Li YF, Fitzgerald E, Kawakami Y, Rosenberg SA. The intronic region of an incompletely-spliced gp100 gene transcript encodes an epitope recognized by melanoma reactive tumor infiltrating lymphocytes. J Immunol 1997;159: 303-8.
16. Wang RF, Robbins PF, Kawakami Y, Kang XQ, Rosenberg SA. Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. J Exp Med 1995;181:799-804.
17. Wang RF, Appella E, Kawakami Y, Kang X, Rosenberg SA. Identification of TRP2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J Exp Med 1996;184:2207-16.
18. Van der Bruggen P, Traversari C, Chomez P, et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991;254:1643-7.
19. Gaugler B, Van Den Eynde B, Van der Bruggen P, et al. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 1994;179:921-30.
20. Cells E, Tsai V, Crimi C, et al. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc Natl Acad Sci USA 1994;91:2105-9.
21. Boel P, Wildmann C, Sensi ML, et al. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 1995;2:167-75.
22. Van Den Eynde B, Peelers O, De Backer O, Gaugler B, Lucas S, Boon TA. New family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med 1995;182:689-98.
23. Robbins PF, El-Gamil M, Li YF, et al. Cloning of a new gene encoding an antigen recognized by melanoma-specific HLA-A24 restricted tumor-infiltrating lymphocytes. J Immunol 1995;154: 5944-50.
24. Guilloux Y, Lucas S, Brichard VG, et al. A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanoma is encoded by an intron sequence of the N-acetylglucosammyltransferase V gene J Exp Med 1996;183:1173-83.
25. Ikeda H, Lethe B, Lehmann F, et al. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 1997;6: 199-8.
26. Kawakami Y, Rosenberg SA, Lotze MT. Interleukin-4 promotes growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma. J Exp Med 1988;168:2183-91.
27. Rosenberg SA, Packard BS, Aebersold PM, et al. Use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. Preliminary report. N Engl J Med 1988;319:1676-80.
28. Rosenberg SA, Yannelli JR, Yang JC, et al. Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2. J Natl Cancer Inst 1995;86:1159-66.
29. Kawakami Y, Eliyahu S, Sakaguchi K, et al. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2 restricted tumor infiltrating lymphocytes. J Exp Med 1994;180:347-52.
30. Kawakami Y, Eliyahu S, Jennings C, et al. Recognition of multiple epitopes in the human melanoma antigen gp100 associated with in vivo tumor regression. J Immunol 1995;154:3961-8.
31. Traversari C, Van der Bruggen P, Luescher IF, et al. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 1992;176:1453-7.
32. Skipper JCA, Kittlesen DJ, Hendrickson RC, et al. Shared epitopes for HLA-A3 restricted melanoma reactive human CTL include a naturally processed epitope from Pmel-17/gp100. J Immunol 1996; 157:5027-33.
33. Kang X-Q, Kawakami Y, Sakaguchi K, et al. Identification of a tyrosinase epitope recognized by HLA-A24 restricted tumor-infiltrating lymphocytes. J Immunol 1995;155:1343-8.
34. Tsai V, Southwood S, Sidney J, et al. Induction of subdominant CTL epitopes of the gp100 melanoma associated tumor antigen by primary in vitro immunization with peptide pulsed dendritic cells. J Immunol 1997;158:1796-802.
35. Wolfel T, Van Pel A, Brichard V, et al. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur J Immunol 1994;24:759-64.
36. Wang R-F, Parkhurst M, Kawakami Y, Robbins PF, Rosenberg SA. Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen. J Exp Med 1996;183:1131-40.
37. Van Pel A, van der Brugen P, Coulie PG, et al. Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol Rev 1995;145:229-50.
38. Kawakami Y, Rosenberg SA. Human tumor antigens recognized by T-cells. Immunol Res 1997;16:313-39.
39. Chakraborty AK, Platt JT, Kim KK, Kwon BB, Bennett DC, Pawelek JM. Polymerization of 5,6-dihydroxyindole-2-carboxylic acid to melanin by the pme117/silver locus protein. Eur J Biochem 1996;236:180-8.
40. Kawakami Y, Battles JK, Kobayashi T, et al. Production of recombinant MART-1 proteins and specific anti-MART-1 polyclonal and monoclonal antibodies: use in the characterization of the human melanoma antigen MART-1. J Immunol Methods 1996; 202:13-25.
41. 27-35. J Exp Med 1996;184:647-57.
42. Brichard VG, Herman J, Van Pel A, et al. A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes. Eur J Immunol 1996;26:224-30.
43. Rosenberg SA, Yang JC, Schwartzentruber DJ, et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nature Med 1998; 4:321-7.
44. Kawakami Y, Rosenberg S. T-cell recognition of self peptides as tumor rejection antigens. Immunol Res 1996;15:179-90.
45. Rosenberg SA, White DE. Vitiligo in patients with melanoma: normal tissue antigens can be target for cancer immunotherapy. J Immunother 1996;19:81-4.